FluINsure™, an inactivated trivalent influenza vaccine for intranasal administration, is protective in human challenge with A/Panama/2007/99 (H3N2) virus

International Congress Series

Volumn 1263, Issue C, 2004, Pages 661-665

  Fries, Louis ^a   Lambkin, Rob ^b   Gelder, Colin ^c   White, Gregory ^d   Burt, David ^d   Lowell, George ^d   Oxford, John ^b  

^a ID Biomedical of Maryland   (United States)

^b Retroscreen Virology Ltd   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d ID Biomedical Corporation of Québec   (Canada)

Author keywords

Human challenge; Influenza; Intranasal; Vaccine

Indexed keywords

EID: 84969181541     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2004.02.024     Document Type: Article

References (10)

1. An evaluation of influenza immunization: influence of route of administration and vaccine strain, R.H., Waldman, et al., Bull. World Health Organ, (1969), 41, 543-548
2. Influenza antibody response following aerosol administration of inactivated virus, R.H., Waldman, et al., Am. J. Epidemiol., (1970), 91, 575-584
3. The protective effect of intranasal immunization with inactivated influenza virus vaccine, K.S., Liem, et al., Postgrad. Med. J., (1973), 49, 175-179
4. Levi, R, et al. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes. Vaccine 13 (1995), 1353–1359.
5. Plante, M, et al. Nasal immunizations with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA, and protection against influenza challenge. Vaccine 20 (2002), 218–225.
6. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers, and protective efficacy against wild-type H1N1 virus challenge, L.F., Fries, et al., J. Infect. Dis., (1993), 167, 593-601
7. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine, M.L., Clements, et al., J. Clin. Microbiol., (1986), 23, 73-76
8. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza, F.G., Hayden, et al., JAMA, (1996), 275, 295-299
9. Influenza viruses, W.N., Dowdle, A.P., Kendall, G.R., Noble, Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, E.H Lenette N.J Schmidt 5th ed. American Public Health Association Wahsington, DC, (1979), 603-605
10. Influenza virus types and subtypes detection by single step single tube multiplex reverse transcription–polymerase chain reaction (RT–PCR) and agarose gel electrophoresis, S.K., Poddar, J. Virol. Methods, (2002), 99, 63-70